Article info

Download PDFPDF

European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy

Authors

  1. Correspondence to kyriaki Tzogani; kyriaki.tzogani{at}ema.europa.eu
View Full Text

Citation

Tzogani K, Florez B, Markey G, et al
European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy

Publication history

  • Received July 31, 2019
  • Accepted August 4, 2019
  • First published September 8, 2019.
Online issue publication 
September 08, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.